Top compounds associated with response to MYT1


Feature Type Standardized
Nominal ANOVA
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.26 1e-15
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.27 8e-13
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 2e-12
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 5e-11
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.24 6e-11
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 7e-11
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.33 5e-10
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 5e-10
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 8e-10
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.2 1e-09
Download CSV